These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7358029)

  • 21. Hepatic estrogen responsiveness. Possible mechanisms for sexual dimorphism.
    Thompson C; Lucier GW
    Mol Pharmacol; 1983 Jul; 24(1):69-76. PubMed ID: 6865928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen receptor in rat adrenal gland.
    Cutler GB; Barnes KM; Sauer MA; Loriaux DL
    Endocrinology; 1978 Jan; 102(1):252-7. PubMed ID: 743950
    [No Abstract]   [Full Text] [Related]  

  • 23. Cyclic AMP-binding protein and estrogen receptor: antagonism during nuclear translocation in a hormone-dependent mammary tumor.
    Bodwin JS; Hirayama PH; Cho-Chung YS
    Biochem Biophys Res Commun; 1981 Dec; 103(4):1349-55. PubMed ID: 6277332
    [No Abstract]   [Full Text] [Related]  

  • 24. Two binding sites for estradiol in rat uterine nuclei: relationship to uterotropic response.
    Markaverich BM; Clark JH
    Endocrinology; 1979 Dec; 105(6):1458-62. PubMed ID: 574077
    [No Abstract]   [Full Text] [Related]  

  • 25. Properties of the estrogen receptor in the human oviduct and its interaction with ethinylestradiol and mestranol in vitro.
    Muechler EK; Kohler D
    J Clin Endocrinol Metab; 1980 Nov; 51(5):962-7. PubMed ID: 7419693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluctuations in levels of cytosol and nuclear estrogen receptors in rat mammary tumors during the estrous cycle.
    Shih A; Lee C
    Endocrinology; 1978 Feb; 102(2):420-5. PubMed ID: 570481
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of low dose continuous exposure to estradiol on the estrogen receptor (type I) and nuclear type II sites.
    Markaverich BM; Roberts RR; Alejandro M; Clark JH
    Endocrinology; 1984 Mar; 114(3):814-20. PubMed ID: 6697964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen causes a rapid, large and prolonged rise in the level of nuclear estrogen receptor in Xenopus laevis liver.
    Westley B; Knowland J
    Biochem Biophys Res Commun; 1979 Jun; 88(3):1167-72. PubMed ID: 465076
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatic nuclear estrogen receptor concentrations in the rat--influence of age, sex, gestation, lactation and estrous cycle.
    Lax ER; Tamulevicius P; Müller A; Schriefers H
    J Steroid Biochem; 1983 Aug; 19(2):1083-8. PubMed ID: 6887919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different nuclear binding sites for antiestrogen and estrogen receptor complexes.
    Ruh TS; Baudendistel LJ
    Endocrinology; 1977 Feb; 100(2):420-6. PubMed ID: 832632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex differences in estrogen binding by cytosolic and nuclear components of rat liver.
    Powell-Jones W; Thompson C; Nayfeh SN; Lucier GW
    J Steroid Biochem; 1980 Feb; 13(2):219-29. PubMed ID: 7382496
    [No Abstract]   [Full Text] [Related]  

  • 32. Translocation of 4S and 5S forms of estrogen-receptors into rat liver nuclei in vitro.
    Powell-Jones W; Nayfeh SN; Lucier GW
    Biochem Biophys Res Commun; 1978 Nov; 85(1):167-73. PubMed ID: 743272
    [No Abstract]   [Full Text] [Related]  

  • 33. Estrogen receptors and androgen receptors in the mammalian liver.
    Eisenfeld AJ; Aten RF
    J Steroid Biochem; 1987; 27(4-6):1109-18. PubMed ID: 3320548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of activation of steroid receptors: involvement of low molecular weight inhibitor in activation of androgen, glucocorticoid, and estrogen receptor systems.
    Sato B; Noma K; Nishizawa Y; Nakao K; Matsumoto K; Yamamura Y
    Endocrinology; 1980 Apr; 106(4):1142-8. PubMed ID: 7358030
    [No Abstract]   [Full Text] [Related]  

  • 35. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen.
    Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Gallion H; Kenady DE
    Endocrinology; 1987 Apr; 120(4):1608-14. PubMed ID: 3830064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A modulator which converts activated estrogen receptor to a biologically inactive aggregated form.
    Nishizawa Y; Maeda Y; Noma K; Sato B; Matsumoto K; Yamamura Y
    Endocrinology; 1981 Nov; 109(5):1463-72. PubMed ID: 6795027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen receptors in the human prostate, seminal vesicle, epididymis, testis, and genital skin: a marker for estrogen-responsive tissues?
    Murphy JB; Emmott RC; Hicks LL; Walsh PC
    J Clin Endocrinol Metab; 1980 May; 50(5):938-48. PubMed ID: 7372780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Facilitation and inhibition of the estrogen-induced luteinizing hormone surge in the rat by progesterone: effects on cytoplasmic and nuclear estrogen receptors in the hypothalamus-preoptic area, pituitary, and uterus.
    Attardi B
    Endocrinology; 1981 Apr; 108(4):1487-96. PubMed ID: 7472278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxytocin receptors and parturition. III. Increases in estrogen receptor and oxytocin receptor concentrations in the rat myometrium during prostaglandin F2 alpha-induced abortion.
    Alexandrova M; Soloff MS
    Endocrinology; 1980 Mar; 106(3):739-43. PubMed ID: 6243549
    [No Abstract]   [Full Text] [Related]  

  • 40. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
    Reiner GC; Katzenellenbogen BS; Bindal RD; Katzenellenbogen JA
    Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.